Pages that link to "Item:Q2767515"
From MaRDI portal
The following pages link to A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach (Q2767515):
Displaying 50 items.
- Optimal bounded controls problem for bilinear systems (Q258789) (← links)
- Analysis of the dynamics of a tumor-immune system with chemotherapy and immunotherapy and quadratic optimal control (Q286487) (← links)
- Personalized drug administration for cancer treatment using model reference adaptive control (Q300902) (← links)
- Effects of the obesity on optimal control schedules of chemotherapy on a cancerous tumor (Q313686) (← links)
- Mathematical modelling and analysis of the tumor treatment regimens with pulsed immunotherapy and chemotherapy (Q332917) (← links)
- The tumor growth paradox and immune system-mediated selection for cancer stem cells (Q371959) (← links)
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments (Q415424) (← links)
- Chaos in a tumor growth model with delayed responses of the immune system (Q443122) (← links)
- Modelling lymphoma therapy and outcome (Q458674) (← links)
- Stability and bifurcation analysis of a mathematical model for tumor-immune interaction with piecewise constant arguments of delay (Q506670) (← links)
- Cost-effectiveness analysis of optimal strategy for tumor treatment (Q508264) (← links)
- Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens (Q520304) (← links)
- Computational modeling of tumor response to vascular-targeting therapies. I: Validation (Q541200) (← links)
- The chaos and optimal control of cancer model with complete unknown parameters (Q603543) (← links)
- Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function (Q630983) (← links)
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
- Mathematical analysis of a tumour-immune interaction model: a moving boundary problem (Q669151) (← links)
- A cancer model for the angiogenic switch (Q739655) (← links)
- On probabilistic certification of combined cancer therapies using strongly uncertain models (Q739722) (← links)
- Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions (Q827852) (← links)
- Chaos and optimal control of cancer self-remission and tumor system steady states (Q944852) (← links)
- A two-compartment model interacting with dynamic drugs (Q1033071) (← links)
- On optimal delivery of combination therapy for tumors (Q1042733) (← links)
- Two-compartment model interacting with proliferating regulatory factor (Q1049244) (← links)
- The dynamics of an optimally controlled tumor model: A case study (Q1433148) (← links)
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes (Q1623948) (← links)
- Combination therapies and intra-tumoral competition: insights from mathematical modeling (Q1642492) (← links)
- A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis (Q1646154) (← links)
- Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment (Q1678512) (← links)
- Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia (Q1712819) (← links)
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine (Q1713207) (← links)
- A two-phenotype model of immune evasion by cancer cells (Q1714296) (← links)
- Bounding the dynamics of a chaotic-cancer mathematical model (Q1721728) (← links)
- Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control (Q1728939) (← links)
- The combined effects of optimal control in cancer remission (Q1732198) (← links)
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
- Periodic and chaotic dynamics in a map-based model of tumor-immune interaction (Q1790827) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- Assessing the effects of estrogen on the dynamics of breast cancer (Q1929569) (← links)
- Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration (Q1981126) (← links)
- Predictive drug dosage control through a Fokker-Planck observer (Q1993658) (← links)
- Extinction and persistence of a tumor-immune model with white noise and pulsed comprehensive therapy (Q1998390) (← links)
- Dynamic analysis of a tumor-immune system under Allee effect (Q2007336) (← links)
- A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia (Q2008906) (← links)
- Optimal control of tumour-immune model with time-delay and immuno-chemotherapy (Q2010733) (← links)
- Spatial avascular growth of tumor in a homogeneous environment (Q2013437) (← links)
- On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
- On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
- Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
- Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy (Q2050026) (← links)
